Original title: Měření adherence u pacientů s cílenou perorální terapií u chronické lymfocytární leukémie
Translated title: Measuring adherence in patients with oral targeted therapy in chronic lymphocytic leukaemia
Authors: Hanusová, Barbora ; Malý, Josef (advisor) ; Kolmanová, Eliška (referee)
Document type: Rigorous theses
Year: 2024
Language: slo
Abstract: [eng] [cze]
Measuring adherence in patients with oral targeted therapy in chronic lymphocytic leukaemia Author: Barbora Hanusová Tutor: doc. PharmDr. Josef Malý, Ph.D. Consultant: PharmDr. Petra Rozsívalová Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Králové, Charles University Introduction and aims: Chronic lymphocytic leukaemia (CLL) is a hematological disorder characterized by clonal proliferation of mature B-cells. New oral targeted drugs have been used in clinical practice to treat CLL. The aim of this thesis was to measure adherence to oral targeted drugs, analyze pharmacotherapy and identify drug-related problems (DRP) and their management. Methods: The cross-sectional pilot study ran from September 2022 to March 2023 in University Hospital Hradec Králové. Patients ≥ 18 years old, with CLL diagnosis treated with ibrutinib, acalabrutinib or venetoclax were included. Medical data and pharmacotherapy were obtained using electronic medical records and patients' medication records. Guided interviews were performed to measure patients' adherence to oral targeted oncolytics using Czech version of The Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS-CZ) and determine their opinions about medicine using Czech translation of The Beliefs about Medicines... Meranie adherencie u pacientov s cielenou perorálnou terapiou u chronickej lymfocytovej leukémie Autor: Barbora Hanusová Vedúci diplomovej práce: doc. PharmDr. Josef Malý, Ph.D. Konzultant: PharmDr. Petra Rozsívalová Katedra sociálnej a klinickej farmácie, Farmaceutická fakulta v Hradci Králové, Univerzita Karlova Úvod a ciele: Chronická lymfocytová leukémia (CLL) je hematologické ochorenie charakterizované klonálnou proliferáciou zrelých B-lymfocytov. V klinickej praxi sú na liečbu CLL využívané nové perorálne cielené liečivá. Cieľom tejto práce bolo meranie adherencie k perorálnym cieleným liečivám, analýza farmakoterapie a identifikácia liekových problémov (DRP) a ich manažment. Metodika: Prierezová pilotná štúdia prebiehala od septembra 2022 do marca 2023 vo Fakultnej nemocnici Hradec Králové. Do štúdie boli zahrnutí pacienti vo veku ≥ 18 rokov s diagnózou CLL liečení ibrutinibom, akalabrutinibom či venetoklaxom. Údaje o zdravotnom stave a farmakoterapii boli získané prostredníctvom zdravotnej dokumentácie a liekového záznamu. S pacientami boli vedené riadené rozhovory s cieľom zmerať ich adherenciu k perorálnym cieleným liečivám pomocou českej verzie dotazníka The Basel Assessment of Adherence to Immunosuppressive Medications Scale (BAASIS-CZ) a zistiť ich názory a postoje na liečivá pomocou...
Keywords: chronic lymphocytic leukaemia; Patient adherence; pharmacotherapy; Adherence k léčbě; chronická lymfocytární leukémie; farmakoterapie

Institution: Charles University Faculties (theses) (web)
Document availability information: Available in the Charles University Digital Repository.
Original record: http://hdl.handle.net/20.500.11956/189793

Permalink: http://www.nusl.cz/ntk/nusl-620222


The record appears in these collections:
Universities and colleges > Public universities > Charles University > Charles University Faculties (theses)
Academic theses (ETDs) > Rigorous theses